STOCK TITAN

Koninklijke Phil Stock Price, News & Analysis

PHG NYSE

Welcome to our dedicated page for Koninklijke Phil news (Ticker: PHG), a resource for investors and traders seeking the latest updates and insights on Koninklijke Phil stock.

Koninklijke Philips N.V. (NYSE: PHG) is a global leader in health technology focused on improving lives through meaningful innovation. This news hub provides investors and healthcare professionals with centralized access to official press releases and verified updates about Philips' advancements in diagnostic imaging, connected care systems, and personal health solutions.

Discover timely information on product launches, regulatory milestones, and strategic partnerships that shape Philips' position in the healthcare sector. Our curated collection includes earnings reports, technology innovations, and market expansion announcements – all essential for understanding the company's trajectory in medical equipment and digital health solutions.

Key updates cover developments in AI-driven diagnostic tools, telehealth platforms, and sustainable healthcare initiatives. Bookmark this page to stay informed about Philips' progress in addressing critical challenges across radiology, cardiology, and home-based patient care through its integrated health technology ecosystem.

Rhea-AI Summary

Royal Philips has successfully priced its offering of EUR 700 million fixed rate notes, set to mature in 2032, under its European Medium Term Note (EMTN) program.

The notes were priced at 98.257% with a 3.75% coupon, resulting in a yield of 4.009%.

The issue, which was over two times oversubscribed, aims to be debt-neutral as it will be used to repay existing debt due in 2024 and 2025.

Philips holds a BBB+ rating from Standard & Poor's and Fitch, and a Baa1 rating from Moody's.

The settlement and issue of the notes are scheduled for May 31, 2024, and the notes will be listed on the Luxembourg Stock Exchange.

This offering is not registered under the U.S. Securities Act and is not intended for retail investors in the EEA or UK.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.77%
Tags
none
-
Rhea-AI Summary

Philips has launched its wearable ePatch and AI-driven Cardiologs analytics platform in 14 hospitals across Spain.

The ePatch, a 14-day continuous Holter monitor, helps detect life-threatening heart arrhythmias like atrial fibrillation (AF).

Dr. Jorge Pagola of University Hospital Vall d'Hebron highlighted its benefits, including enhanced patient comfort and reduced hospital stays, which saved approximately €28,800 in 2023.

More than 1500 patients are currently being monitored using ePatch devices, reducing wait times and improving care access.

Studies show the ePatch detects 2.5 times more arrhythmias over 14 days compared to traditional 24-hour Holter monitors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.48%
Tags
AI
-
Rhea-AI Summary

Philips Foundation released its 2023 Annual Report, showcasing efforts to improve healthcare access for over 28 million people in underserved communities, aligning with its 2030 goal to reach 100 million annually.

The report highlights 17 new initiatives and 4 new investments in health tech enterprises leveraging Philips' expertise.

Key focus areas include mother and child health, non-communicable disease detection, and acute care services, emphasizing early screening and diagnosis.

Philips Foundation supports social enterprises, with 13 projects backed in 2023, creating an ecosystem to boost growth and impact.

Chair of the Board, Marnix van Ginneken, affirmed the foundation's commitment to sustainable healthcare development and collaboration with various partners.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.26%
Tags
none
Rhea-AI Summary

Philips showcased the benefits of its AI-powered cardiac monitoring solutions at the Heart Rhythm Annual Meeting. Three studies highlighted how Philips' Mobile Cardiac Outpatient Telemetry (MCOT) wearable ECG and AI models improve diagnosis, reduce readmissions, and lower costs. A study published in The Journal of Comparative Effectiveness Research found that MCOT reduces readmissions in stroke patients (30.2% vs. 35.4% with ILR), lowers costs by USD 27,429 over 18 months, and increases survival rates.

Additional research demonstrated that AI-driven ECG technology aids in identifying potentially life-threatening arrhythmias and accurately diagnosing syncope causes. Another study revealed that urgent notifications from MCOT led to timely follow-ups and procedural interventions, enhancing patient outcomes.

Philips will also educate on managing cardiac implantable electronic device (CIED) infections, offering comprehensive lead management solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.89%
Tags
AI
-
Rhea-AI Summary

Royal Philips (NYSE: PHG) announced the exchange ratio for its 2023 dividend, set at 1 new common share for every 29.2684 existing shares. This ratio, based on a volume-weighted average price of EUR 24.8481 on Euronext Amsterdam, equates to a gross dividend of approximately EUR 0.85 per share. Philips plans to issue a total of 30,860,582 new common shares. Distribution and settlement are scheduled for May 16, 2024. Furthermore, Philips will cancel 4,437,164 shares acquired under its EUR 1.5 billion share repurchase program, reducing the total share count to 939,939,384.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.82%
Tags
dividends
-
Rhea-AI Summary

Royal Philips announced that its shareholders approved all proposals at the Annual General Meeting of Shareholders (AGM) 2024, including key appointments and resolutions. Feike Sijbesma and Peter Löscher were re-appointed to the Supervisory Board, Benoît Ribadeau-Dumas was appointed as a new member, and Charlotte Hanneman was appointed to the Board of Management as Chief Financial Officer. The resolutions included the adoption of the financial statements for 2023, a dividend of EUR 0.85 per common share, and positive advisory votes on the Remuneration Report 2023. The AGM also approved the Remuneration Policy for the Board of Management and the Supervisory Board, authorized the issuance and acquisition of shares, and cancelled shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.38%
Tags
none
Rhea-AI Summary

Philips Avent partners with March of Dimes for the It Starts With Mom initiative, supporting new moms with resources for health and well-being. The partnership aims to benefit local communities, NICU families, and maternity care deserts. A recent survey showed the need for support for new moms, and Philips Avent's Share the Care campaign advocates for community involvement in baby care to allow moms more time for self-care. The initiative highlights the importance of maternal health, with various programs and partnerships focusing on supporting families globally.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.38%
Tags
none
-
Rhea-AI Summary

Royal Philips and Nicklaus Children’s Health System announced a 10-year strategic collaboration to enhance patient and staff experiences in pediatric care. Philips will provide AI-enabled diagnostic technologies, including MR and ultrasound systems, to improve exam efficiency, reduce the need for rescans, and increase diagnostic confidence. Patient experience technologies like Ambient Experience and Scan Buddy App will help kids feel more comfortable during MRIs. Philips will also enhance Nicklaus Children’s cardiac care with advanced ultrasound systems to automate measurements, reduce exam times, and improve diagnostic accuracy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.6%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.02%
Tags
none

FAQ

What is the current stock price of Koninklijke Phil (PHG)?

The current stock price of Koninklijke Phil (PHG) is $24.52 as of July 2, 2025.

What is the market cap of Koninklijke Phil (PHG)?

The market cap of Koninklijke Phil (PHG) is approximately 22.1B.
Koninklijke Phil

NYSE:PHG

PHG Rankings

PHG Stock Data

22.13B
925.01M
6.49%
0.26%
Medical Devices
Healthcare
Link
Netherlands
Amsterdam